Press release from Companies: DanCann Pharma A/S announces outcome of the Rights Issue

Press release from Companies: DanCann Pharma A/S: Last day of subscription of shares in the ongoing Rights Issue is 20 June 2024 on Nordnet Bank and Avanza Bank

Press release from Companies: DanCann Pharma A/S: Solid growth in the Rx portfolio

Press release from Companies: DanCann Pharma A/S: Germany trends – prescriptions for medicinal cannabis positively influenced by new legalization

Press release from Companies: DanCann Pharma A/S: Submits applications for FLS03 and FLS04 to expand portfolio

Press release from Companies: DanCann Pharma A/S: The subscription period of DanCann Pharma’s Rights Issue begins today

Press release from Companies: DanCann Pharma A/S: Publishes Q1-2024 Report

Press release from Companies: DanCann Pharma A/S: Minutes OF ANNUAL GENERAL MEETING

Press release from Companies: DanCann Pharma A/S: The Board of Directors has resolved on a partially (48.88 percent) secured Rights Issue of approximately DKK 18.33 million and publishes memorandum

Press release from Companies: DanCann Pharma A/S: Capital reduction completed

Press release from Companies: NOTICE OF ANNUAL GENERAL MEETING 2024 IN DANCANN PHARMA A/S

Press release from Companies: DanCann Pharma A/S Publishes Its Annual Report for 2023: A Year of Strategic Review and Future Focus on Capital Efficiency and Profitability